Quan Jiang
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Dedifferentiated Liposarcoma Presenting as Primary Diffuse Peritoneal Sarcomatosis: A Case Report and Literature Review.
Journal: Journal of gastrointestinal cancer
Published: April 08, 2026
Stemness-based gastric cancer classification by machine learning for precision diagnosis and treatment of gastric cancer.
Journal: Journal of gastrointestinal oncology
Published: November 01, 2024
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 25, 2023
Correction: Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression via the Wnt Pathway.
Journal: Molecular cancer research : MCR
Published: September 02, 2022
Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: March 24, 2022
Integrated Analysis of Stemness-Related LncRNAs Helps Predict the Immunotherapy Responsiveness of Gastric Cancer Patients.
Journal: Frontiers in cell and developmental biology
Published: July 11, 2021
Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Journal: Annals of translational medicine
Published: June 17, 2021
Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer.
Journal: BMC cancer
Published: May 12, 2021
Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients.
Journal: Frontiers in oncology
Published: January 07, 2021
Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression via the Wnt Pathway.
Journal: Molecular cancer research : MCR
Published: October 22, 2020
Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors.
Journal: Oncoimmunology
Published: September 13, 2019
Last Updated: 09/26/2026